跳至主要内容
临床试验/CTRI/2023/08/056441
CTRI/2023/08/056441尚未招募2 期

A Randomized Open Labeled Comparative Clinical Study To Evaluate The Efficacy Of Pratimarsha Nasya With Shatapushpa Taila And Tila Taila In Artava Kshaya w.s.r. To Oligomenorrhea

Dr Netra Karjagi1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年8月24日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Improvement in flow of menstrual bleeding, Interval between 2 cycles

研究概览

简要总结

  • Streeroga includes an array of diseases, among which Artava Dushti indicates menstrual disorders. The ultimate effect of Artava Vyapath is Abeejatva, diagnosis and treatment of Artava Vyapath is essential
  • Artava Kshaya is a condition in which menstruation fails to occur at appropriate time (delayed) with scanty flow and does not last for 3 days.3
  • A similar entity in contemporary science, where menstrual bleeding occurring more than 35 days apart and which remains constant at the frequency is called oligomenorrhea.
  • The treatment opted in modern system of medicine is hormonal therapy, which may have adverse effect on body like obesity, nausea, vomiting, endometrial cancer and breast cancer.
  • Acharya says “Nasa Hi Shiraso Dwaram†i.e. Nasa is said to be the door of Shiras because Nasa is indirectly connected with the brain centers in the head.
  • As Nasya helps in regulating hypothalamus where GnRH is produced and is also connected with pituitary gland which produces hormones like FSH, LH, estrogen, progesterone and prolactin thus resulting in regulation of HPO axis.
  • Nasya is very convenient to the patients due to its easy procedure and less requirement of time. Hence Shatapushpa Taila and Tila Taila Nasya is expecting to benificial results in Artavakshaya and hence taken for the study.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • •1.Subjects of age group between 18 years to 40 years.
  • •2.Both married and unmarried women.
  • •3.Subjects presenting with classical symptoms of Artava Kshaya.
  • •4.Subjects presenting with symptoms of Oligomenorrhea.
  • •5.Subjects with Poly Cystic Ovaries.

排除标准

  • •1.Subjects with history of PID, Tuberculosis, Pelvic Endometriosis, Adenomyosis.
  • •2.Subjects with known cases of Hypertension, Thyroid disorders, Anemia.
  • •3.Subjects with any known case of Benign and Malignant tumors.
  • •4.Subjects with Congenital Anomalies.
  • •5.Nasya Ayogya.

结局指标

主要结局

Improvement in flow of menstrual bleeding, Interval between 2 cycles

时间窗: Before treatment 0th day | after treatment - after subjects gets her cycle

次要结局

  • Reduction of pain during menstruation, number of pads.(0th Day ,After subject gets her cycle (Maximum study duration 42 days))

研究者

发起方
Dr Netra Karjagi
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验